Isodiol International (Isodiol International) Debt-to-Revenue : 1.10 (As of Dec. 2019)

View and export this data going back to 2014. Start your Free Trial

What is Isodiol International Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Isodiol International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $0.13 Mil. Isodiol International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $4.31 Mil. Isodiol International's annualized Revenue for the quarter that ended in Dec. 2019 was $4.02 Mil. Isodiol International's annualized Debt-to-Revenue for the quarter that ended in Dec. 2019 was 1.10.

Isodiol International Debt-to-Revenue Historical Data

The historical data trend for Isodiol International's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isodiol International Debt-to-Revenue Chart

Isodiol International Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Debt-to-Revenue

Get a 7-Day Free Trial

N/A

54.39

0.70

0.36

Isodiol International Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Debt-to-Revenue	Get a 7-Day Free Trial															0.22	0.24	0.36	0.77	1.10

Competitive Comparison of Isodiol International's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Isodiol International's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Isodiol International's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Isodiol International's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Isodiol International's Debt-to-Revenue falls into.

Isodiol International Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Isodiol International's Debt-to-Revenue for the fiscal year that ended in Mar. 2019 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(2.173	+	3.882)	/	16.639
	=	0.36

Isodiol International's annualized Debt-to-Revenue for the quarter that ended in Dec. 2019 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.129	+	4.31)	/	4.024
	=	1.10

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2019) Revenue data.

Isodiol International Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Isodiol International's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Isodiol International (Isodiol International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Isodiol International Inc (OTCPK:ISOLF) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Granville Street, Suite 2710, Vancouver, BC, CAN, V6C 1S4

Website

https://www.isodiol.com

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.